Clinical trials
Coronavirus Infections clinical trials
Below are recruiting coronavirus infections clinical trials, each written for real people, not researchers. We’re tracking 19 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04359836Recruiting
Study of gut bacteria in early COVID-19
This trial studies how gut bacteria (“gut flora”) may affect COVID-19 after a recent infection. If you test positive for COVID-19 soon enough, the study may help researchers understand why some people get better faster or have different symptoms.
Ventura, CaliforniaAges 18 years+ - NCT01904188Recruiting
Rapid identification of infection germs and antibiotic resistance
This study tests whether a faster lab method can correctly identify the germ causing an infection and check which antibiotics may work, using samples taken in the emergency department. It may help doctors choose the right treatment sooner for people with serious suspected infection.
Lansing, MichiganAges 18 years+ - NCT07221097Recruiting
Testing a new panel to detect COVID-19 and other coronaviruses
This trial uses leftover nasal swab samples to test a new panel that can detect COVID-19 and other coronaviruses. It helps see if the panel works well for diagnosing these infections.
Los Angeles, CaliforniaAges Any age - NCT04367857Recruiting
Study of COVID antibody levels in healthcare workers
This study measures how many healthcare workers have COVID antibodies (proof of past infection or immune response). Results may help estimate how widespread COVID exposure has been among hospital staff.
New York, New YorkAges 18 years+ - NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT04326426Enrolling by invitationPhase 3
Study of tradipitant for severe or critical COVID-19
This trial tests whether tradipitant can improve outcomes for adults with severe or critical COVID-19, including pneumonia and low oxygen. It may help patients whose lungs are significantly affected and who need careful hospital-level care.
New York, New YorkAges 18–90 - NCT04429594Recruiting
Study tracking COVID-19 infection rates in the public
This study looks at how often SARS-CoV-2 (the virus that causes COVID-19) infection happens in people who may have been exposed in the community. It may help researchers understand infection rates and patterns in the general population.
NiceAges 18 years+ - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Phoenix, ArizonaAges birth–20 years - NCT04318366Recruiting
Study of COVID-19 samples and how patients respond to treatment
This trial collects and studies COVID-19 test results and other patient information to better predict treatment response and outcomes. Your sample(s) help researchers understand who may improve, worsen, or need different care.
Milan, LombardyAges 18 years+ - NCT04327570Recruiting
Study of immune responses in hospitalized COVID-19 patients
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
LeuvenAges 18 years+ - NCT04510025Recruiting
MRI study of whole-body effects of moderate to severe COVID
This study looks at how COVID-19 affects multiple organs in the body, using MRI scans and related measurements. It may help researchers better understand who is at risk for longer-lasting or widespread effects after COVID.
OxfordAges 18–100 - NCT05141058RecruitingPhase 1
T cell therapy to help prevent COVID-19 after transplant
This Phase 1 trial tests a donated immune-cell treatment (T cells) to help immunocompromised people fight or resist COVID-19 after they recently received a bone marrow or stem cell transplant. It aims to see if the treatment is safe and if it helps the body respond better to the virus.
Washington D.C., District of ColumbiaAges 2–80 - NCT04362150Recruiting
Study of long-term effects after COVID-19 infection
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
San Francisco, CaliforniaAges 18–100 - NCT06099795Recruiting
Breath test vs. swab test for COVID-19
This study checks if a new breath test (eBAM-CoV) can accurately detect COVID-19 compared to the usual nose/throat swab test (RT-PCR). If you have symptoms or were exposed and are getting tested anyway, you may be able to help by also providing a breath sample.
NîmesAges 18 years+ - NCT04887623Recruiting
Blood and breathing marker tracking in hospitalized COVID-19
This study follows hospitalized people with recent COVID-19 to see how infection and inflammation markers change over time. It may help doctors better understand what’s happening in the body as breathing problems develop and treatments are given.
Hradec KrálovéAges 18–90 - NCT06667063Recruiting
Immune response study for COVID-19 and flu
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
Wuhan, HubeiAges 18 years+ - NCT05164744Recruiting
MRI study of heart tissue changes after COVID-19
This study uses a heart MRI to look for leftover (healing) changes in heart tissue after COVID-19. It may help researchers better understand what ongoing heart effects can happen after infection.
Brooklyn, New YorkAges 18 years+ - NCT05656105RecruitingEarly Phase 1
PET scan study of brain inflammation after COVID
This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.
Birmingham, AlabamaAges 18–65 - NCT04320732Recruiting
Study COVID-19 spread at home and work
This study looks at what factors make COVID-19 spread more easily in the community and workplace. It may help researchers understand how to reduce transmission in everyday settings.
OsloAges 18 years+
Hear when a new Coronavirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Coronavirus Infections trials by city
Studies with a site in or near these metro areas.
Coronavirus Infections trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for coronavirus infections?
- Yes. Clin2 currently lists 19 recruiting coronavirus infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coronavirus infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coronavirus infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.